S-A. Im

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study

Xin Su, Ping Zhan, Paul R. Gavine et al. · British Journal of Cancer · 2014 · 183 citations · Full text

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer

Heon‐Jeong Lee, An Na Seo, Eunice Kim et al. · British Journal of Cancer · 2014 · 142 citations · Full text

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim et al. · The Lancet Oncology · 2019 · 120 citations

Breast Oncology, Medicine, Pharmacology +8

Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer

Hyoung‐Pyo Kim, S-W Han, SH Song et al. · Oncogene · 2013 · 108 citations · Full text

Tumor Biology, Oncology, Gastrointestinal Oncology +10

Abstract S5-07: Preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer enrolled in KEYNOTE-028

HS Rugo, J.P. Delord, S-A. Im et al. · Cancer Research · 2016 · 97 citations

Breast Oncology, Immunology, Immunoediting +18